Education

PhD, China Agricultural University, 2015

BSc, China Agricultural University, 2008

Research Interest

My research focuses on investigating signaling pathways involved in immunological regulation, developing innovative cell-based therapies to combat inflammation and tumors, and advancing vaccine development by addressing Vaccine-Associated Enhanced Respiratory Disease (VAERD).

Selected Publications

T. Zhang, et al; Th2 and Th17-associated immunopathology following SARS-CoV-2 breakthrough infection in Spike-vaccinated ACE2-humanized mice. J Med Virol 96 (2024) e29408.

N. Magazine, T. Zhang, et al; Immune Epitopes of SARS-CoV-2 Spike Protein and Considerations for Universal Vaccine Development. Immunohorizons 8 (2024) 214-226. 3).

N. Magazine, T. Zhang, et al; Mutations and Evolution of the SARS-CoV-2 Spike Protein. Viruses 14 (2022).

M.C. McGee, T. Zhang, et al; PD-1 and ICOS counter-regulate tissue resident regulatory T cell development and IL-10 production during flu. PD-1 and ICOS counter-regulate tissue resident regulatory T cell development and IL-10 production during flu - PubMed.

T. Zhang, et al; Genetic Removal of the CH1 Exon Enables the Production of Heavy Chain-Only IgG in Mice. Front Immunol 9 (2018) 2202.

T. Zhang, et al; Intraclass diversification of immunoglobulin heavy chain genes in the African lungfish. Immunogenetics 66 (2014) 335-51.